The processing costs involved in regional accent normalization were evaluated by measuring differences in lexical decision latencies for targets placed at the end of sentences with different French regional accents. Over a series of 6 experiments, the authors examined the time course of comprehension disruption by manipulating the duration and presentation conditions of accented speech. Taken together, the findings of these experiments indicate that regional accent normalization involves a short-term adjustment mechanism that develops as a certain amount of accented signal is available, resulting in a temporary perturbation in speech processing.

This study examines children's ability to detect accent-related information in connected speech. British English children aged 5 and 7 years old were asked to discriminate between their home accent from an Irish accent or a French accent in a sentence categorization task. Using a preliminary accent rating task with adult listeners, it was first verified that the level of accentedness was similar across the two unfamiliar accents. Results showed that whereas the younger children group behaved just above chance level in this task, the 7-year-old group could reliably distinguish between these variations of their own language, but were significantly better at detecting the foreign accent than the regional accent. These results extend and replicate a previous study (Girard, Floccia, & Goslin, 2008) in which it was found that 5-year-old French children could detect a foreign accent better than a regional accent. The factors underlying the relative lack of awareness for a regional accent as opposed to a foreign accent in childhood are discussed, especially the amount of exposure, the learnability of both types of accents, and a possible difference in the amount of vowels versus consonants variability, for which acoustic measures of vowel formants and plosives voice onset time are provided.

This study examines children's metaphonological awareness for accent-related information in connected speech. In the first experiment, 5-to 6-year-old Frenchspeaking children were asked to discriminate between Southern and Northern accented French in a sentence categorization task. It was found that these children were not able to reliably distinguish between these native variations of their own language, but were able to distinguish between their own accent and a strong foreign accent in Experiment 2. These findings were also replicated using a speaker discrimination task in Experiment 3, where children were asked to detect pairs of speakers sharing the same accent amongst speaker pairs with different accents. Whilst these experiments have shown that 5-to 6-year-old children do not use non-familiar regional accents as a discriminatory cue, they are able to perceive the differences between accents, as demonstrated in the AX task used in Experiment 4. The factors underlying the relative lack of awareness for a regional accent as opposed to a foreign accent in childhood are discussed, especially regarding the amount of exposure and the learnability of both types of accents.

No abstract

PSA, the only relevant marker for prostate cancer, has a low predictive value; moreover its low threshold leads to unnecessary biopsies with associated complications. Identification of prognostic factors is an important goal in prostate cancer. In the search for new markers, clusterin, has some potential as it is closely linked with cancer progression and resistance to apoptosis. We looked at the expression of secreted clusterin (sCLU) in prostate cells to determine correlations with progression and drug resistance. The plasmatic expression of sCLU was also investigated in order to use it as a potential marker for prostate cancer. sCLU expression was studied using Western blotting on cultured prostate cells, PWR-1E, PC3 and PC3 Docetaxel resistant cells in the cytosol and culture medium. An inhouse ELISA test was developed to determine sCLU expression in culture media and plasma samples. A patient cohort was identified from the Prostate Cancer Research Consortium Bio-Resource and plasmatic expression of sCLU was studied using western blotting and the inhouse ELISA test. Only the fully processed form of sCLU was identified in the medium of cells with increased expression associated with increased progression of disease and resistance to docetaxel. Plasmatic expression of sCLU was significantly higher in the plasma of patients with high grade prostate cancer with extracapsular extension than in the plasma of prostate cancer patients without extracapsular extension. Plasmatic sCLU may be an effective prognostic marker of prostate cancer and needs to be tested in a multimarker approach.